Center-Authored Papers

Filters: Author is Duerr, Ann  [Clear All Filters]
2008
Morgan C, Marthas M, Miller C, Duerr A, Cheng-Mayer C, Desrosiers R, Flores J, Haigwood N, Hu S-lok, Johnson PR et al..  2008.  The use of nonhuman primate models in HIV vaccine development.. PLoS medicine. 5(8):e173.
Jaspan HB, Cunningham CK, Tucker TJP, Wright PF, Self SG, Sheets RL, Rogers AS, Bekker L-G, Wilson CM, Duerr A et al..  2008.  Inclusion of adolescents in preventive HIV vaccine trials: public health policy and research design at a crossroads.. Journal of acquired immune deficiency syndromes (1999). 47(1):86-92. Abstract
Sunderam S, Hollander L, Macaluso M, Vucetich A, Jamieson DJ, Osimo F, Duerr A, Semprini AE.  2008.  Safe conception for HIV discordant couples through sperm-washing: experience and perceptions of patients in Milan, Italy.. Reproductive health matters. 16(31):211-9. Abstract
Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, Gilbert PB, Lama JR, Marmor M, del Rio C et al..  2008.  Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.. Lancet. 372(9653):1881-93. Abstract
2009
Maclachlan E, Mayer KH, Barnabas R, Sanchez J, Koblin B, Duerr A.  2009.  The potential role of biomarkers in HIV preventive vaccine trials.. Journal of acquired immune deficiency syndromes (1999). 51(5):536-45. Abstract
Paramsothy P, Jamieson DJ, Heilig CM, Schuman PC, Klein RS, Shah KV, Rompalo AM, Cu-Uvin S, Duerr A.  2009.  The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology.. Obstetrics and gynecology. 113(1):26-31. Abstract
van der Horst C, Chasela C, Ahmed Y, Hoffman I, Hosseinipour M, Knight R, Fiscus S, Hudgens M, Kazembe P, Bentley M et al..  2009.  Modifications of a large HIV prevention clinical trial to fit changing realities: a case study of the Breastfeeding, Antiretroviral, and Nutrition (BAN) protocol in Lilongwe, Malawi.. Contemporary clinical trials. 30(1):24-33. Abstract
2010
Graham BS, McElrath MJ, Keefer MC, Rybczyk K, Berger D, Weinhold KJ, Ottinger J, Ferarri G, Montefiori DC, Stablein D et al..  2010.  Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity.. PloS one. 5(8):e11995. Abstract
Cheng C, Gall JGD, Nason M, King RC, Koup RA, Roederer M, McElrath MJ, Morgan CA, Churchyard G, Baden LR et al..  2010.  Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization.. Journal of virology. 84(1):630-8. Abstract
Theiler RN, Farr SL, Karon JM, Paramsothy P, Viscidi R, Duerr A, Cu-Uvin S, Sobel J, Shah K, Klein RS et al..  2010.  High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding.. Obstetrics and gynecology. 115(6):1150-8. Abstract
Gray G, Buchbinder S, Duerr A.  2010.  Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine.. Current opinion in HIV and AIDS. 5(5):357-61. Abstract
Duerr A.  2010.  Update on mucosal HIV vaccine vectors.. Current opinion in HIV and AIDS. 5(5):397-403. Abstract
2011
Nicholson O, Dicandilo F, Kublin J, Sun X, Quirk E, Miller M, Gray G, Pape J, Robertson MN, Mehrotra DV et al..  2011.  Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults.. AIDS research and human retroviruses. 27(5):557-567. Abstract
Migueles SA, Rood JE, Berkley AM, Guo T, Mendoza D, Patamawenu A, Hallahan CW, Cogliano NA, Frahm N, Duerr A et al..  2011.  Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles.. PLoS pathogens. 7(2):e1002002. Abstract
Curlin ME, Cassis-Ghavami F, Magaret AS, Spies GA, Duerr A, Celum CL, Sanchez JL, Margolick JB, Detels R, McElrath MJ et al..  2011.  Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case-control study.. AIDS (London, England). 25(2):153-8. Abstract
Duerr A, Gallo MF, Warner L, Jamieson DJ, Kulczycki A, Macaluso M.  2011.  Assessing male condom failure and incorrect use.. Sexually transmitted diseases. 38(7):580-6. Abstract
Kingkeow D, McNicholl JM, Maneekarn N, Wongtrakul J, Taechareonkul S, Suriyanon V, Nelson KE, Duerr A, Makonkawkeyoon S.  2011.  Frequencies of IL10 SNP genotypes by multiplex PCR-SSP and their association with viral load and CD4 counts in HIV-1-infected Thais.. Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand. 29(1):94-101. Abstract
Rolland M, Tovanabutra S, Decamp AC, Frahm N, Gilbert PB, Sanders-Buell E, Heath L, Magaret CA, Bose M, Bradfield A et al..  2011.  Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial.. Nature medicine. 17(3):366-71. Abstract
Fitzgerald DW, Janes H, Robertson M, Coombs R, Frank I, Gilbert PB, Loufty M, Mehrotra D, Duerr A.  2011.  An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: results from a randomized placebo-controlled trial (the Step study).. The Journal of infectious diseases. 203(6):765-72. Abstract
2012
Duerr A, Altice FL, Harries AD, Sohn AH.  2012.  Antiretroviral treatment in resource-limited settings 2012.. AIDS research and treatment. 2012:346708.
Saganic L, Carr J, Solorio R, Courogen M, Jaenicke T, Duerr A.  2012.  Comparing Measures of Late HIV Diagnosis in Washington State.. AIDS research and treatment. 2012:182672. Abstract
Frahm N, Decamp AC, Friedrich DP, Carter DK, Defawe OD, Kublin JG, Casimiro DR, Duerr A, Robertson MN, Buchbinder SP et al..  2012.  Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine.. The Journal of clinical investigation. 122(1):359-67. Abstract
Duerr A, Huang Y, Buchbinder S, Coombs RW, Sanchez J, del Rio C, Casapia M, Santiago S, Gilbert P, Corey L et al..  2012.  Extended Follow-up Confirms Early Vaccine-Enhanced Risk of HIV Acquisition and Demonstrates Waning Effect Over Time Among Participants in a Randomized Trial of Recombinant Adenovirus HIV Vaccine (Step Study).. The Journal of infectious diseases. 206(2):258-266. Abstract
Duerr A.  2012.  HIV treatment as protection: next steps.. Current opinion in HIV and AIDS. 7(2):97-8.
2013
Duerr A, Huang Y, Buchbinder S, Coombs RW, Sanchez J, del Rio C, Casapia M, Santiago S, Huang Y, Gilbert P et al..  2013.  Reply to richie and villasante.. The Journal of infectious diseases. 207(4):690-2.